CSPC Pharmaceutical Group Limited (1093.HK)
HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
As of 03:47PM HKT. Market open.
Currency in HKD
Valuation measures4
| Market cap (intra-day) | 79.58B |
| Enterprise value | 66.21B |
| Trailing P/E | 12.52 |
| Forward P/E | 11.67 |
| PEG ratio (5-yr expected) | 2.67 |
| Price/sales (ttm) | 2.34 |
| Price/book (mrq) | 2.22 |
| Enterprise value/revenue | 1.95 |
| Enterprise value/EBITDA | 7.19 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.70 |
| 52-week change 3 | -10.32% |
| S&P500 52-week change 3 | 26.36% |
| 52-week high 3 | 7.750 |
| 52-week low 3 | 5.200 |
| 50-day moving average 3 | 6.321 |
| 200-day moving average 3 | 6.265 |
Share statistics
| Avg vol (3-month) 3 | 42.18M |
| Avg vol (10-day) 3 | 42.25M |
| Shares outstanding 5 | 11.9B |
| Implied shares outstanding 6 | 12.13B |
| Float 8 | 8.26B |
| % held by insiders 1 | 29.86% |
| % held by institutions 1 | 32.18% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.28 |
| Forward annual dividend yield 4 | 4.19% |
| Trailing annual dividend rate 3 | 0.25 |
| Trailing annual dividend yield 3 | 3.80% |
| 5-year average dividend yield 4 | 2.13 |
| Payout ratio 4 | 46.38% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 31 May 2024 |
| Last split factor 2 | 8:5 |
| Last split date 3 | 16 Oct 2020 |
Financial highlights
Currency in CNY.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 18.67% |
| Operating margin (ttm) | 23.59% |
Management effectiveness
| Return on assets (ttm) | 9.96% |
| Return on equity (ttm) | 18.22% |
Income statement
| Revenue (ttm) | 31.45B |
| Revenue per share (ttm) | 2.65 |
| Quarterly revenue growth (yoy) | 1.90% |
| Gross profit (ttm) | N/A |
| EBITDA | 7.93B |
| Net income avi to common (ttm) | 5.87B |
| Diluted EPS (ttm) | 0.530 |
| Quarterly earnings growth (yoy) | -15.10% |
Balance sheet
| Total cash (mrq) | 13.76B |
| Total cash per share (mrq) | 1.16 |
| Total debt (mrq) | 706.9M |
| Total debt/equity (mrq) | 2.02% |
| Current ratio (mrq) | 2.63 |
| Book value per share (mrq) | 2.80 |
Cash flow statement
| Operating cash flow (ttm) | 4.18B |
| Levered free cash flow (ttm) | 1.16B |
© 2024 Yahoo. All rights reserved.